About: Plasma Protein Binding of Gyrase Inhibitors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Plasma Protein Binding of Gyrase Inhibitors Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1998 (uk) article scientifique publié en 1998 (fr) im Februar 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1998 (ast) artikull shkencor i botuar më 01 shkurt 1998 (sq) scientific article published on 01 February 1998 (en)
publication date	wds:Q58856381-BB7DDCD3-6DE9-4BDC-B91B-F39B226125CD
publication date	1998-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58856381-EC138A91-6665-4798-B2D9-253AB23A43E5
language of work or name	English
cites work	wds:Q58856381-22B7F182-2D20-45DA-A63B-E91271C42040 wds:Q58856381-2B086D79-D8BE-4C58-ADB7-FF5D3D7FBFE8 wds:Q58856381-6B52A7A8-938F-46B1-BB4D-24BF2927CED8 wds:Q58856381-9BDDA707-D678-47C8-9C32-BAA96B8005B3 wds:Q58856381-B43FE451-BB03-4024-AB84-F57970EDBD64 wds:Q58856381-BEF08AF0-C52C-499E-B643-C647A67D8A30 wds:Q58856381-F1C03C2A-0193-4022-84F7-F95461DC3603
cites work	Protonation equilibria of quinolone antibacterials On the partition of ampholytes: application to blood-brain distribution. Syntheses and Biological Activities of NewN1-Aryl Substituted Quinolone Antibacterials Lack of effect of ofloxacin on theophylline pharmacokinetics in rats High-performance liquid chromatographic assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolone antibiotic Fleroxacin: a review of its chemistry, microbiology, toxicology, pharmacokinetics, clinical efficacy and safety Accidental overdose of intravenous ofloxacin with benign outcome
author name string	wds:Q58856381-4D9151F9-97B7-4ACE-8FBA-A5DCC9CCE481 wds:Q58856381-5BCA3C4A-AE39-40E3-9790-FF66DC2BDB1C wds:Q58856381-9385F966-3568-468A-A031-59FC3715D731 wds:Q58856381-96E3C986-2BE6-4A83-BB04-5D7B57766224
author name string	Kinzig-Schippers M Bücker A Sorgel F Zlotos G
rdfs:label	Plasma Protein Binding of Gyrase Inhibitors (en) Plasma Protein Binding of Gyrase Inhibitors (nl) Plasma Protein Binding of Gyrase Inhibitors (sq)
skos:prefLabel	Plasma Protein Binding of Gyrase Inhibitors (en) Plasma Protein Binding of Gyrase Inhibitors (nl) Plasma Protein Binding of Gyrase Inhibitors (sq)
name	Plasma Protein Binding of Gyrase Inhibitors (en) Plasma Protein Binding of Gyrase Inhibitors (nl) Plasma Protein Binding of Gyrase Inhibitors (sq)
author	wds:Q58856381-2DA0FC3E-5704-46D3-B577-D588C9AA1EA0
author	Ulrike Holzgrabe
title	wds:Q58856381-4782DAC1-AF4C-4FED-BCD7-03ED43CD42DB
title	Plasma protein binding of gyrase inhibitors (en)
page(s)	wds:Q58856381-6A110801-1465-4605-847F-C0977520FFC7
page(s)	215-220
instance of	wds:Q58856381-3DF25E8F-2829-4F7F-831E-EBA6398EB822
instance of	scholarly article
PubMed ID	wds:Q58856381-95545153-CCA9-4F7D-9018-DA4A1CAD658A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9519156
PubMed ID	9519156
published in	wds:Q58856381-437C3FE3-7302-4D89-AAAE-0DA12E91998B
published in	Journal of Pharmaceutical Sciences
issue	wds:Q58856381-AC19FF00-3CB9-4A74-A786-9B9349DD0625
volume	wds:Q58856381-C953F40C-C371-4EC1-8268-EB436664006F
issue	2
volume	87
DOI	wds:Q58856381-A8C3A1EC-893C-4355-BB8B-D364548D1D33
DOI	http://dx.doi.org/10.1021/JS970181B
DOI	10.1021/JS970181B
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58856381
is cites work of	Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. Predicting plasma protein binding of drugs: a new approach Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability A novel approach to determining physicochemical and absorption properties of 6-fluoroquinolone derivatives: experimental assessment. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model A simulation model for the prediction of tissue:plasma partition coefficients for drug residues in natural casings MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species Determination of protein binding of gyrase inhibitors by means of continuous ultrafiltration Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey. Investigation of the prerequisites for the optimization of specific plasma protein binding as a strategy for the reduction of first-pass hepatic metabolism. Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters. Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens Prediction of the residue levels of drugs in eggs, using physicochemical properties and their influence on passive diffusion processes Use of a linear gradient flow program for liquid chromatography-mass spectrometry protein-binding studies Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics
is cites work of	wds:Q33990437-431B04AD-2175-4364-A3B3-A476D6039826 wds:Q44930645-3EBBF7BA-74DB-493B-94EF-C1B1E2C65261 wds:Q44658891-EF13B69B-E7C7-4073-8587-701FFF1A2544 wds:Q44863085-325576B3-E390-4079-A583-5B574598941D wds:Q51794212-81393C7A-8633-46EB-9161-376C0DB69836 wds:Q40111934-440EEE28-3F48-4742-BEED-C360ED2F0E38 wds:Q46047517-AF559DB9-DF50-4B70-86E6-45ECBA1A27C5 wds:Q84472417-129B30A0-791C-4690-B902-C07AEF25C9DC wds:Q39405890-A194C364-2692-49DC-B481-55A9ADF0C11F wds:Q34271413-4EC9A4BF-49E5-4FC9-AE2A-19CB715EF811 wds:Q46908564-4A7C5113-9018-4AF9-8C51-921B655B38FE wds:Q35081931-1DDD3137-C0C7-432B-8457-51E8C67002A3 wds:Q44872030-8BC7563F-B206-47E3-814B-8BD5A6C55B58 wds:Q51038149-820C3029-AA3A-41B0-80A0-F9CE791DD9D8 wds:Q91801588-794D802F-4AD9-43B3-8CE4-BB874A773878 wds:Q37995676-3728E612-9FBC-44F4-96C0-EB9F92D12764

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software